Study of Cortisol Metabolism in Familial Partial Lipodystrophy Type 2
Condition(s):Familial Partial Lipodystrophy Type 2Last Updated:June 27, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Familial Partial Lipodystrophy Type 2Last Updated:June 27, 2022Recruiting
Condition(s):Generalized LipodystrophyLast Updated:March 12, 2024Active, not recruiting
Condition(s):Generalized LipodystrophyLast Updated:February 26, 2024Active, not recruiting
Condition(s):Lipodystrophy; Diabetes; HyperlipidemiaLast Updated:February 26, 2024Recruiting
Condition(s):Lipodystrophy; Insulin ResistanceLast Updated:October 8, 2020Completed
Condition(s):Lipodystrophy; Dunnigan SyndromeLast Updated:October 30, 2023Recruiting
Condition(s):Lipodystrophy; Dunnigan SyndromeLast Updated:October 25, 2023Completed
Condition(s):Lipodystrophy Acquired; Lipodystrophy CongenitalLast Updated:December 12, 2023Recruiting
Condition(s):Familial Partial LipodystrophyLast Updated:February 15, 2023Available
Condition(s):Insulin Resistance – Type A; Insulin Resistance – Type B; Lipoatrophic Diabetes Mellitus; Insulin Resistance SyndromeLast Updated:June 3, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.